|
|
|
|
Chronic Lymphocytic Leukemia
BIRMINGHAM, Ala., December 06, 2004 /PRNewswire-FirstCall ... Dec 7, 2004
Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including cutaneous T-cell lymphoma; chronic lymphocytic leukemia (CLL) and ... PharmaLive.com
Abstracts Demonstrate that ONTAK May Benefit Patients with ... Dec 7, 2004
...reported in abstract 4824, there was a 40 per cent response rate among the 10 evaluable patients with fludarabine-refractory B-cell chronic lymphocytic leukemia ... PharmaLive.com
Point Therapeutics Reports Results of Phase 1 Study of Talabostat ... Dec 5, 2004
Twenty patients with indolent NHL (including patients with small lymphocytic lymphoma (SLL) or chronic lymphocytic leukemia (CLL)) received talabostat for six ... RedNova.com
Genta Shares Soar on Positive Trial News Dec 6, 2004
The company also released more detailed data Monday from a late-stage human trial of Genasense with people suffering from chronic lymphocytic leukemia. ... Forbes
Phase 2 Study of Genasense(R) Plus Mylotarg(R) Yields Complete ... Dec 5, 2004
...with AML can tolerate full doses of Genasense without risk for developing the "cytokine release reaction" that has been observed in chronic lymphocytic leukemia ... RedNova.com
Seattle Genetics Reports on SGN-30 and SGN-40 Clinical Programs at ... Dec 6, 2004
...antigen, which is expressed on most B-cell lineage hematologic malignancies, including multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia ... Business Wire
Genta's Programs in Blood Cancers Featured in Presentations at the ... Nov 29, 2004
Investigators will discuss study results in a variety of hematological cancers, including chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma, acute ... Yahoo News
113 Abstracts on Recent Clinical Data for Thalomid(R), Revlimid(TM ... Nov 30, 2004
Blood Stem Cells in 668 Patients with Multiple Myeloma Treated on Total Therapy II (UARK 98-026); Abstract #5236 Chronic Lymphocytic Leukemia: -- Thalidomide (T ... PR Newswire
Inex, Enzon, ILEX, Genzyme Part Of Today's ODAC Panel Nov 30, 2004
In addition to clofarabine, ILEX has been earning revenue from sales of Campath (alemtuzumab for injection) for B-cell chronic lymphocytic leukemia. ... BioWorld Online (subscription)
Genta buys drug rights Dec 3, 2004
On Monday, Berkeley Heights-based Genta is scheduled to present data on the ability of its lead product Genasense to treat chronic lymphocytic leukemia. ... Newark Star Ledger
Left in the cold Dec 3, 2004
...for single men. Earlier this year, while battling chronic lymphocytic leukemia, Berg was forced to scale back his work. Nobody in ... Arizona Daily Sun
Seattle Genetics Expands SGN-40 Clinical Program into Non ... Dec 2, 2004
Seattle Genetics is also considering potential applications of SGN-40 in other indications such as chronic lymphocytic leukemia, certain solid tumors and ... dBusinessNews Seattle
XOMA and Chiron Announce Preclinical Data Presentations on CHIR ... Dec 2, 2004
...-- "In Vitro Activity of a Novel Fully Human Anti-CD40 Antibody CHIR-12.12 in Chronic Lymphocytic Leukemia: Blockade of CD40 Activation and Induction of ADCC ... Business Wire
Genta Announces 2nd Quarter 2004 Financial Results Aug 3, 2004
...of this year. These trials include a total of 465 patients with either multiple myeloma or chronic lymphocytic leukemia. If the ... PR Newswire
BioCrist Jumps on FDA Ruling Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia and related leukemias as well as acute lymphoblastic leukemia. ... TheStreet.com
BioCryst Receives Orphan Drug Designation for BCX-1777 in Two ... Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia (CLL) and related leukemias to include prolymphocytic leukemia, adult T-cell ... Yahoo News
BIOCRYST CANCER COMPOUND RECEIVES ORPHAN DRUG STATUS FOR TWO ... Aug 24, 2004
...newest designations are for the drug’s potential treatment of acute lymphoblastic leukemia and for the treatment of chronic lymphocytic leukemia and related ... Pharmexec
FDA speeds BioCryst anti-cancer drug Aug 24, 2004
...leukemia. The two new indications are for treatment of chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). ... Birmingham Business Journal
AVI Biopharma, 8X8, Toro, more Aug 24, 2004
Administration. The added indications are for treatment of chronic lymphocytic leukemia and acute lymphoblastic leukemia. Caterpillar ... Investor's Business Daily (subscription)
Toronto cancer researchers get $3.1 million boost Aug 25, 2004
...at University Health Network. "Chronic Lymphocytic Leukemia (CLL) is the most common blood cancer in Canada. Drugs can decrease ... CNW Telbec (Communiqués de presse)
Pharmacyclics Reports Fourth Quarter and Fiscal 2004 Financial ... Aug 19, 2004
Presented preliminary results from an ongoing Phase 2 trial evaluating Xcytrin as a single agent for the treatment of relapsed chronic lymphocytic leukemia (CLL ... Yahoo News
Listeria Infections in Cancer Patients Aug 24, 2004
Listeriosis is a serious threat to cancer patients, especially those with chronic lymphocytic leukemia or acute lymphoblastic leukemia. ... Medscape (subscription)
Point Therapeutics Reports Second Quarter 2004 Results Aug 5, 2004
...as a single agent -- advanced metastatic melanoma patients combining talabostat with cisplatin -- advanced chronic lymphocytic leukemia patients combining ... Business Wire
Point Therapeutics Annual Shareholders' Meeting Held in Boston ... Aug 3, 2004
...and in combination with cisplatin in advanced metastatic melanoma, and in combination with rituximab in patients with advanced chronic lymphocytic leukemia. ... Business Wire
Puget Sound Journal: He wanted more than a diagnosis from his ... Aug 13, 2004
But it wasn't until 1997 that he was diagnosed with chronic lymphocytic leukemia, a slow-moving form of cancer that has been linked to Agent Orange exposure. ... Seattle Post Intelligencer
Gene expression pattern may predict leukemia behavior Aug 11, 2004
...of certain genes may someday help doctors to diagnose and predict whether or not an individual has an aggressive form of B-cell chronic lymphocytic leukemia. ... ScienceBlog.com
FDA Safety Labeling Changes: August 4, 2004 Aug 4, 2004
Alemtuzumab is indicated in the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and who have failed ... Medscape (subscription)
Genmab Announces 2004 First Half Year Results Aug 3, 2004
Genmab's Investigational New Drug application for a HuMax-CD20 Phase I/II study to treat patients with relapsed or refractory Chronic Lymphocytic Leukemia. ... Yahoo News
Rituximab is the Most Promising Emerging Drug for Chronic ... May 24, 2004
...care issues, finds that rituximab (Biogen Idec/Genentech's Rituxan, Roche's MabThera) is the most promising emerging drug for chronic lymphocytic leukemia (CLL ... PR Newswire
Preliminary Results of a Phase III Study Showed Rituxan ... Jun 5, 2004
...been described as paraneoplastic pemphigus and are known to be associated with various B-cell lymphomas, particularly NHL and chronic lymphocytic leukemia (CLL ... Yahoo News
Flat Stanley's a travelin ' man Jun 4, 2004
Michael Cremons is suffering from chronic lymphocytic leukemia. The disease attacks the bone marrow, lymph nodes, liver, spleen and other organs. ... Cincinnati Enquirer
Early Treatment of Younger Patients with Aggressive CLL with ... May 24, 2004
...high-dose chemotherapy with autologous peripheral blood stem cell transplantation for younger patients with aggressive chronic lymphocytic leukemia (CLL). ... Cancer Consultants
Titan Initiates Phase II Clinical Studies of Pivanex(R) in ... May 24, 2004
...(ASE: TTP) today announced the initiation of two Phase II clinical studies of Pivanex in the treatment of refractory chronic lymphocytic leukemia (CLL) and ... Yahoo News
Student from Mt. Carmel High training for Physics Olympiad May 27, 2004
The Escondido elementary schools superintendent, who recently completed chemotherapy for chronic lymphocytic leukemia, said his most recent medical tests show ... San Diego Union Tribune
Portsmouth firm captures DNA legacy on CD for posterity May 23, 2004
...preserved. Clark has CLL-chronic lymphocytic leukemia — which turned into non-Hodgkin’s lymphoma. His brother died of leukemia. ... The Union Leader (subscription)
Outgoing mayor gives his thanks May 28, 2004
...will support charities such as the Yurt Project, with promotes story-telling for children and charities dealing with chronic lymphocytic leukemia, which she ... Streatham Guardian
Veterans officers receive training May 24, 2004
...are hearing about new things the VA is doing, new ways to file claims and about new benefits, such as those for chronic lymphocytic leukemia n recently ... Rapid City Journal
Larry G. Pickering Joins Point Therapeutics' Board of Directors May 24, 2004
...in metastatic melanoma in combination with cisplatin, as a single-agent therapeutic in metastatic melanoma, and in chronic lymphocytic leukemia in combination ... Business Wire
BC and BU Awarded Program Project Grant to Study White Blood ... May 13, 2004
...the molecular basis of several human lymphoproliferative disorders associated with B-1a cells, including a form of cancer called chronic lymphocytic leukemia. ... Medical News Today
Genta Slashes Work Force To Curb Spending, Conserve Cash May 13, 2004
Schmitt said two other randomized trials have completed enrollment - one in chronic lymphocytic leukemia and the other in multiple myeloma. ... BioWorld Online (subscription)
Genta's setback shows risk of market May 9, 2004
...business strategy, it pursued studies on the drug as a treatment for skin cancer and the two blood cancers, multiple myeloma and chronic lymphocytic leukemia. ... Newark Star Ledger
Xcyte Therapies initiated with " market perform " - update May 19, 2004
Piper Jaffray expresses its optimism regarding the positive phase I/II trials data for this immunotherapy in chronic lymphocytic leukemia and multiple myeloma ... New Ratings
OSI Pharmaceuticals Announces Second Quarter Financial Results; ... May 11, 2004
OSI-461 is also currently being evaluated in a series of preliminary Phase II studies in chronic lymphocytic leukemia, renal cell carcinoma and prostate cancer ... Business Wire
NDA Withdrawn, But Genta's Genasense Work To Continue May 14, 2004
Two other Phase III trials have completed accrual, she noted - one in chronic lymphocytic leukemia and one in multiple myeloma. ... BioWorld Online (subscription)
Genta downgraded after it withdraws drug application May 14, 2004
However, the company is also testing Genasense as a treatment for chronic lymphocytic leukemia and multiple myeloma in two separate, ongoing Phase III trials. ... Investor's Business Daily (subscription)
Research, not arguments, is the answer May 19, 2004
...not immune to error and has been forced to reverse itself before, most recently reversing a long-standing finding that chronic lymphocytic leukemia (CLL) was ... Andalusia Star-News
A strong show of support May 20, 2004
Frank, who is being treated at the Dana Farber Cancer Institute for Chronic Lymphocytic Leukemia (CLL), is at a critical stage in her illness and is in dire ... Norwell Mariner
Female Obesity Linked to Leukemia -- 07 Nov 2004
...older Iowa women over 14 years and found 200 of the women developed leukemia -- 74 were diagnosed with AML and 88 with chronic lymphocytic leukemia, or CLL. ... / RedNova.com,
Xcyte Therapies initiated with "sector perform" -- Nov 5, 2004
The company plans to initiate pivotal trials for the treatment of chronic lymphocytic leukemia and non-hodgkins lymphoma in 2005, the analyst adds. ... / New Ratings
Point Therapeutics Reports Additional Supportive Clinical and ... -- Nov 4, 2004
...therapy with cisplatin in advanced metastatic melanoma, and combination therapy with rituximab in patients with advanced chronic lymphocytic leukemia. ... / Business Wire (press release),
Gemin X Biotechnologies Initiates Phase 1 Clinical Trial with ... -- Nov 4, 2004
In addition to the Phase I trial for solid tumor indications, the company expects to begin separate Phase I trials in Chronic Lymphocytic Leukemia (CLL) both ... / Business Wire (press release),
Point Therapeutics Reports Third Quarter 2004 Results -- Nov 2, 2004
...a single agent; Advanced metastatic melanoma studying talabostat in combination with cisplatin; and Advanced chronic lymphocytic leukemia studying talabostat ... / Business Wire (press release),
Leukemia a broad range of diseases -- Oct 28, 2004
...and progress quickly. Chronic lymphocytic leukemia and chronic myelogenous leukemia both progress more slowly. Symptoms include ... / Reuters AlertNet,
Leukemia victim profile in courage -- Nov 2, 2004
Eric, Matthew, David and Peter - who watched this brave, selfless man take the news of his eventual death sentence from chronic lymphocytic leukemia, aka CLL ... / New York Daily News,
Preliminary Phase IIB Data Show Rituxan(R) Improved Symptoms in ... -- Nov 1, 2004
...have been described as paraneoplastic pemphigus and are known to be associated with various B-cell lymphomas, particularly NHL and chronic lymphocytic leukemia ... / PR Newswire (press release)
Rodman & Renshaw Techvest 6th Annual Healthcare Conference -- Oct 25, 2004
...and in combination with cisplatin in advanced metastatic melanoma, and in combination with rituximab in patients with advanced chronic lymphocytic leukemia. ... / Business Wire (press release),
Canadian Diplomat Crosses Borders and Runs to Help Fight Blood ... -- Oct 24, 2004
I have lost a co-worker to chronic lymphocytic leukemia and another of my co-workers lost her 10-year-old son to cancer,� said Lupul. ... / Onlypunjab.com,
Looking for Mr. or Ms. Perfect: Stem cell donor sought -- Oct 28, 2004
In July 2001, the Muenster resident was diagnosed with chronic lymphocytic leukemia. Since then he has undergone different regimens of chemotherapy treatments. ... / Gainesville Daily Register,
Clinical Trials Update: Oct. 6, 2004 -- Oct 6, 2004
A research study to compare the effectiveness and safety of standard treatment with an investigational medication in patients with chronic lymphocytic leukemia ... / HealthCentral.com
BioCryst Pharmaceuticals Initiates Oral Phase I Clinical Trial in ... -- Oct 19, 2004
Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including cutaneous T-cell lymphoma; chronic lymphocytic leukemia (CLL) and ... / Yahoo News (press release)
MaxCyte to Be Featured at the BIO Emerging Company Investor Forum ... -- Oct 12, 2004
MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical ... / Yahoo News (press release)
FDA OK's new formulation of ILEX's drug Campath -- Oct 18, 2004
...single dose vial. ILEX developed the drug in 2001 as a treatment for patients with B-cell chronic lymphocytic leukemia. Berlex, a ... / San Antonio Business Journal,
The LiveStrong band: fundraiser or fad? -- Oct 8, 2004
The publicity that has come with the LiveStrong bands has irritated Chiplis, whose dad was diagnosed with Chronic Lymphocytic Leukemia, a cancer of the blood ... / Silver Chips Online,
CAMPATH(R) (Alemtuzumab for Injection) Approved for Marketing in ... -- Oct 18, 2004
...in June 2001, and in Europe, where it is named MABCAMPATH, in August 2001 for the treatment of patients with B-cell chronic lymphocytic leukemia who have been ... / Yahoo News (press release)
ZymoGenetics and Serono to Begin TACI-Ig Clinical Studies in B ... -- Oct 4, 2004
...advanced B-cell malignancies. These include chronic lymphocytic leukemia, multiple myeloma, and B-cell non-Hodgkin's lymphoma. In the US ... / Business Wire (press release),
Biotech sells rights to drug candidate -- Oct 5, 2004
...firm Serono, plan to begin testing TACI-Ig's safety in patients with several B-cell-related cancers, including chronic lymphocytic leukemia, multiple myeloma ... / Seattle Times,
Protein Expression Predicts Aggressiveness of Chronic Lymphocytic ... -- Sep 1, 2004
...in The New England Journal of Medicine, levels of expression of the protein ZAP-70 predicts the aggressiveness of chronic lymphocytic leukemia in younger ... / Cancer Consultants (press release),
Component in Green Tea Helps Kill Leukemia Cells -- Sep 10, 2004
...survive. Researchers studied cells taken from patients who have B-cell chronic lymphocytic leukemia, a noncurable form of the disease. ... / innovations report,
Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a ... -- Aug 16, 2004
The B lymphocyte clone expanded in chronic lymphocytic leukemia (B-CLL) expresses low levels of surface membrane Ig, the B cell antigen receptor (BCR). ... / Journal of Experimental Medicine
Xcyte Therapies, Inc. to Present at the Roth Capital Partners New ... -- Sep 8, 2004
Xcyte is currently conducting clinical trials of Xcellerated T Cells(TM) in patients with chronic lymphocytic leukemia, non-Hodgkin's lymphoma, and multiple ... / Business Wire (press release),
Lookingglass woman tenacious, witty -- Sep 7, 2004
She had such a positive attitude. She could look at the bright side of life.". Buckle, 74, died Aug. 15 from chronic lymphocytic leukemia. ... / The News-Review,
Test Predicts Course of Rare Leukemia -- Aug 25, 2004
25 (HealthDayNews) -- A new test for a genetic marker will give some people with chronic lymphocytic leukemia (CLL) peace of mind, but at the same time will ... / Forbes
ZAP-70 is a Strong Predictor for Progression of CLL -- Aug 26, 2004
Researchers affiliated with the Chronic Lymphocytic Leukemia Research Consortium have reported that the presence of the abnormal protein, ZAP 70, is a stronger ... / Cancer Consultants (press release),
ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation ... -- Aug 25, 2004
Thomas J. Kipps, MD, Ph.D. Background The course of chronic lymphocytic leukemia (CLL) is variable. In aggressive disease, the CLL ... / New England Journal of Medicine (subscription),
Test could differentiate leukemias -- Aug 26, 2004
A blood test for a protein dubbed ZAP-70 can tell which chronic lymphocytic leukemia patients have aggressive disease and will need early treatment and which ... / San Diego Union Tribune,
Puget Sound Journal: He wanted more than a diagnosis from his ... -- Aug 13, 2004
But it wasn't until 1997 that he was diagnosed with chronic lymphocytic leukemia, a slow-moving form of cancer that has been linked to Agent Orange exposure. ... / Seattle Post Intelligencer,
Gene expression pattern may predict leukemia behavior -- Aug 11, 2004
...of certain genes may someday help doctors to diagnose and predict whether or not an individual has an aggressive form of B-cell chronic lymphocytic leukemia. ... / ScienceBlog.com
BioCrist Jumps on FDA Ruling -- Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia and related leukemias as well as acute lymphoblastic leukemia. ... / TheStreet.com,
BioCryst Receives Orphan Drug Designation for BCX-1777 in Two ... -- Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia (CLL) and related leukemias to include prolymphocytic leukemia, adult T-cell ... / Yahoo News (press release)
BIOCRYST CANCER COMPOUND RECEIVES ORPHAN DRUG STATUS FOR TWO ... -- Aug 24, 2004
...newest designations are for the drug’s potential treatment of acute lymphoblastic leukemia and for the treatment of chronic lymphocytic leukemia and related ... / Pharmexec (press release)
FDA speeds BioCryst anti-cancer drug -- Aug 24, 2004
...leukemia. The two new indications are for treatment of chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). ... / Birmingham Business Journal,
AVI Biopharma, 8X8, Toro, more -- Aug 24, 2004
Administration. The added indications are for treatment of chronic lymphocytic leukemia and acute lymphoblastic leukemia. Caterpillar ... / Investor's Business Daily (subscription)
Toronto cancer researchers get $3.1 million boost -- Aug 25, 2004
...at University Health Network. "Chronic Lymphocytic Leukemia (CLL) is the most common blood cancer in Canada. Drugs can decrease ... / CNW Telbec (Communiqués de presse),
Pharmacyclics Reports Fourth Quarter and Fiscal 2004 Financial ... -- Aug 19, 2004
Presented preliminary results from an ongoing Phase 2 trial evaluating Xcytrin as a single agent for the treatment of relapsed chronic lymphocytic leukemia (CLL ... / Yahoo News (press release)
Blocked by the border -- Aug 16, 2004
In early October, Leonard got the diagnosis: chronic lymphocytic leukemia, probably caused by exposure to Agent Orange in Vietnam. ... / AL.com,
BIRMINGHAM, Ala., December 06, 2004 /PRNewswire-FirstCall ... Dec 7, 2004
Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including cutaneous T-cell lymphoma; chronic lymphocytic leukemia (CLL) and ... PharmaLive.com (press release),
Abstracts Demonstrate that ONTAK May Benefit Patients with ... Dec 7, 2004
...reported in abstract 4824, there was a 40 per cent response rate among the 10 evaluable patients with fludarabine-refractory B-cell chronic lymphocytic leukemia ... PharmaLive.com (press release),
Point Therapeutics Reports Results of Phase 1 Study of Talabostat ... Dec 5, 2004
Twenty patients with indolent NHL (including patients with small lymphocytic lymphoma (SLL) or chronic lymphocytic leukemia (CLL)) received talabostat for six ... RedNova.com,
Genta Shares Soar on Positive Trial News Dec 6, 2004
The company also released more detailed data Monday from a late-stage human trial of Genasense with people suffering from chronic lymphocytic leukemia. ... Forbes,
Phase 2 Study of Genasense(R) Plus Mylotarg(R) Yields Complete ... Dec 5, 2004
...with AML can tolerate full doses of Genasense without risk for developing the "cytokine release reaction" that has been observed in chronic lymphocytic leukemia ... RedNova.com,
Seattle Genetics Reports on SGN-30 and SGN-40 Clinical Programs at ... Dec 6, 2004
...antigen, which is expressed on most B-cell lineage hematologic malignancies, including multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia ... Business Wire (press release),
Genta's Programs in Blood Cancers Featured in Presentations at the ... Nov 29, 2004
Investigators will discuss study results in a variety of hematological cancers, including chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma, acute ... Yahoo News (press release)
113 Abstracts on Recent Clinical Data for Thalomid(R), Revlimid(TM ... Nov 30, 2004
Blood Stem Cells in 668 Patients with Multiple Myeloma Treated on Total Therapy II (UARK 98-026); Abstract #5236 Chronic Lymphocytic Leukemia: -- Thalidomide (T ... PR Newswire (press release)
Inex, Enzon, ILEX, Genzyme Part Of Today's ODAC Panel Nov 30, 2004
In addition to clofarabine, ILEX has been earning revenue from sales of Campath (alemtuzumab for injection) for B-cell chronic lymphocytic leukemia. ... BioWorld Online (subscription)
Genta buys drug rights Dec 3, 2004
On Monday, Berkeley Heights-based Genta is scheduled to present data on the ability of its lead product Genasense to treat chronic lymphocytic leukemia. ... Newark Star Ledger,
Left in the cold Dec 3, 2004
...for single men. Earlier this year, while battling chronic lymphocytic leukemia, Berg was forced to scale back his work. Nobody in ... Arizona Daily Sun,
Seattle Genetics Expands SGN-40 Clinical Program into Non ... Dec 2, 2004
Seattle Genetics is also considering potential applications of SGN-40 in other indications such as chronic lymphocytic leukemia, certain solid tumors and ... dBusinessNews Seattle (press release),
XOMA and Chiron Announce Preclinical Data Presentations on CHIR ... Dec 2, 2004
...-- "In Vitro Activity of a Novel Fully Human Anti-CD40 Antibody CHIR-12.12 in Chronic Lymphocytic Leukemia: Blockade of CD40 Activation and Induction of ADCC ... Business Wire (press release),
Genta Announces 2nd Quarter 2004 Financial Results Aug 3, 2004
...of this year. These trials include a total of 465 patients with either multiple myeloma or chronic lymphocytic leukemia. If the ... PR Newswire (press release)
BioCrist Jumps on FDA Ruling Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia and related leukemias as well as acute lymphoblastic leukemia. ... TheStreet.com,
BioCryst Receives Orphan Drug Designation for BCX-1777 in Two ... Aug 24, 2004
The two additional indications are for treatment of chronic lymphocytic leukemia (CLL) and related leukemias to include prolymphocytic leukemia, adult T-cell ... Yahoo News (press release)
BIOCRYST CANCER COMPOUND RECEIVES ORPHAN DRUG STATUS FOR TWO ... Aug 24, 2004
...newest designations are for the drug’s potential treatment of acute lymphoblastic leukemia and for the treatment of chronic lymphocytic leukemia and related ... Pharmexec (press release)
FDA speeds BioCryst anti-cancer drug Aug 24, 2004
...leukemia. The two new indications are for treatment of chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). ... Birmingham Business Journal,
AVI Biopharma, 8X8, Toro, more Aug 24, 2004
Administration. The added indications are for treatment of chronic lymphocytic leukemia and acute lymphoblastic leukemia. Caterpillar ... Investor's Business Daily (subscription)
Toronto cancer researchers get $3.1 million boost Aug 25, 2004
...at University Health Network. "Chronic Lymphocytic Leukemia (CLL) is the most common blood cancer in Canada. Drugs can decrease ... CNW Telbec (Communiqués de presse),
Pharmacyclics Reports Fourth Quarter and Fiscal 2004 Financial ... Aug 19, 2004
Presented preliminary results from an ongoing Phase 2 trial evaluating Xcytrin as a single agent for the treatment of relapsed chronic lymphocytic leukemia (CLL ... Yahoo News (press release)
Listeria Infections in Cancer Patients Aug 24, 2004
Listeriosis is a serious threat to cancer patients, especially those with chronic lymphocytic leukemia or acute lymphoblastic leukemia. ... Medscape (subscription)
Point Therapeutics Reports Second Quarter 2004 Results Aug 5, 2004
...as a single agent -- advanced metastatic melanoma patients combining talabostat with cisplatin -- advanced chronic lymphocytic leukemia patients combining ... Business Wire (press release),
Point Therapeutics Annual Shareholders' Meeting Held in Boston ... Aug 3, 2004
...and in combination with cisplatin in advanced metastatic melanoma, and in combination with rituximab in patients with advanced chronic lymphocytic leukemia. ... Business Wire (press release),
Puget Sound Journal: He wanted more than a diagnosis from his ... Aug 13, 2004
But it wasn't until 1997 that he was diagnosed with chronic lymphocytic leukemia, a slow-moving form of cancer that has been linked to Agent Orange exposure. ... Seattle Post Intelligencer,
Gene expression pattern may predict leukemia behavior Aug 11, 2004
...of certain genes may someday help doctors to diagnose and predict whether or not an individual has an aggressive form of B-cell chronic lymphocytic leukemia. ... ScienceBlog.com
FDA Safety Labeling Changes: August 4, 2004 Aug 4, 2004
Alemtuzumab is indicated in the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and who have failed ... Medscape (subscription)
Genmab Announces 2004 First Half Year Results Aug 3, 2004
Genmab's Investigational New Drug application for a HuMax-CD20 Phase I/II study to treat patients with relapsed or refractory Chronic Lymphocytic Leukemia. ... Yahoo News (press release)
Rituximab is the Most Promising Emerging Drug for Chronic ... May 24, 2004
...care issues, finds that rituximab (Biogen Idec/Genentech's Rituxan, Roche's MabThera) is the most promising emerging drug for chronic lymphocytic leukemia (CLL ... PR Newswire (press release)
Preliminary Results of a Phase III Study Showed Rituxan ... Jun 5, 2004
...been described as paraneoplastic pemphigus and are known to be associated with various B-cell lymphomas, particularly NHL and chronic lymphocytic leukemia (CLL ... Yahoo News (press release)
Flat Stanley's a travelin ' man Jun 4, 2004
Michael Cremons is suffering from chronic lymphocytic leukemia. The disease attacks the bone marrow, lymph nodes, liver, spleen and other organs. ... Cincinnati Enquirer,
Early Treatment of Younger Patients with Aggressive CLL with ... May 24, 2004
...high-dose chemotherapy with autologous peripheral blood stem cell transplantation for younger patients with aggressive chronic lymphocytic leukemia (CLL). ... Cancer Consultants (press release),
Titan Initiates Phase II Clinical Studies of Pivanex(R) in ... May 24, 2004
...(ASE: TTP) today announced the initiation of two Phase II clinical studies of Pivanex in the treatment of refractory chronic lymphocytic leukemia (CLL) and ... Yahoo News (press release)
Student from Mt. Carmel High training for Physics Olympiad May 27, 2004
The Escondido elementary schools superintendent, who recently completed chemotherapy for chronic lymphocytic leukemia, said his most recent medical tests show ... San Diego Union Tribune,
Portsmouth firm captures DNA legacy on CD for posterity May 23, 2004
...preserved. Clark has CLL-chronic lymphocytic leukemia — which turned into non-Hodgkin’s lymphoma. His brother died of leukemia. ... The Union Leader (subscription),
Outgoing mayor gives his thanks May 28, 2004
...will support charities such as the Yurt Project, with promotes story-telling for children and charities dealing with chronic lymphocytic leukemia, which she ... Streatham Guardian,
Veterans officers receive training May 24, 2004
...are hearing about new things the VA is doing, new ways to file claims and about new benefits, such as those for chronic lymphocytic leukemia n recently ... Rapid City Journal,
Larry G. Pickering Joins Point Therapeutics' Board of Directors May 24, 2004
...in metastatic melanoma in combination with cisplatin, as a single-agent therapeutic in metastatic melanoma, and in chronic lymphocytic leukemia in combination ... Business Wire (press release),
BC and BU Awarded Program Project Grant to Study White Blood ... May 13, 2004
...the molecular basis of several human lymphoproliferative disorders associated with B-1a cells, including a form of cancer called chronic lymphocytic leukemia. ... Medical News Today,
Genta Slashes Work Force To Curb Spending, Conserve Cash May 13, 2004
Schmitt said two other randomized trials have completed enrollment - one in chronic lymphocytic leukemia and the other in multiple myeloma. ... BioWorld Online (subscription)
Genta's setback shows risk of market May 9, 2004
...business strategy, it pursued studies on the drug as a treatment for skin cancer and the two blood cancers, multiple myeloma and chronic lymphocytic leukemia. ... Newark Star Ledger,
Xcyte Therapies initiated with " market perform " - update May 19, 2004
Piper Jaffray expresses its optimism regarding the positive phase I/II trials data for this immunotherapy in chronic lymphocytic leukemia and multiple myeloma ... New Ratings
OSI Pharmaceuticals Announces Second Quarter Financial Results; ... May 11, 2004
OSI-461 is also currently being evaluated in a series of preliminary Phase II studies in chronic lymphocytic leukemia, renal cell carcinoma and prostate cancer ... Business Wire (press release)
NDA Withdrawn, But Genta's Genasense Work To Continue May 14, 2004
Two other Phase III trials have completed accrual, she noted - one in chronic lymphocytic leukemia and one in multiple myeloma. ... BioWorld Online (subscription)
Genta downgraded after it withdraws drug application May 14, 2004
However, the company is also testing Genasense as a treatment for chronic lymphocytic leukemia and multiple myeloma in two separate, ongoing Phase III trials. ... Investor's Business Daily (subscription)
Research, not arguments, is the answer May 19, 2004
...not immune to error and has been forced to reverse itself before, most recently reversing a long-standing finding that chronic lymphocytic leukemia (CLL) was ... Andalusia Star-News,
A strong show of support May 20, 2004
Frank, who is being treated at the Dana Farber Cancer Institute for Chronic Lymphocytic Leukemia (CLL), is at a critical stage in her illness and is in dire ... Norwell Mariner,
Chronic Lymphocytic Leukemia
-->
The Leukemia & Lymphoma Society's Career Development Program ... -- Apr 30, 2004
...of a research sponsor. The role of monoclonal antibodies in the therapy of chronic lymphocytic leukemia (CLL). It is hoped that ... (Yahoo News)
Woodlands majority owner dies at 69 -- Apr 27, 2004
...death. In Houston, Grace was a board member of the recently formed International Chronic Lymphocytic Leukemia Research Institute. ... (Kansas City Star (subscription))
Health Scan: A little hole in the heart can cause big headaches -- Apr 24, 2004
The leukemia cells studied were from patients with B-cell chronic lymphocytic leukemia (CLL) -- most often diagnosed in patients in their mid-to-late 60s. ... (Jerusalem Post)
Supervisor plans to whip cancer, defeat opponents -- Apr 25, 2004
At first I thought I was just going to curl up and die," said Pace, 52, who was diagnosed in January with chronic lymphocytic leukemia and small lymphocytic ... (Flint Journal)
DOUBLE DESIGNS Michigan artists open new exhibitions at Studio 23 -- Apr 22, 2004
Steel, who was diagnosed with chronic lymphocytic leukemia in the mid-90s, says his illness has inspired him to complete his life's work. ... (MLive.com)
Green Tea Component Kills Leukemia Cells -- Apr 5, 2004
In a previous report, Kay's team had shown that certain cancer cells, known as chronic lymphocytic leukemia cells, release a chemical called vascular ... (Reuters)
Green tea treats Leukemia -- Apr 8, 2004
The scientists say a component of green tea helps kill cells of B-cell chronic lymphocytic leukemia (CLL), the second most common leukemia in American adults ... (Pravda)
Green Tea Component Kills Leukemia Cells -- Apr 8, 2004
THURSDAY, April 8 (HealthDayNews) -- A component of green tea helps kill cells of B-cell chronic lymphocytic leukemia (CLL), the second most common leukemia in ... (Atlanta Journal Constitution)
Green Tea Component Might Fight Leukemia -- Apr 2, 2004
...need to survive. The cells used in the study were from patients with B-cell chronic lymphocytic leukemia, or CLL. It's most often ... (Milwaukee Channel.com)
Healthcast: Migraines; Tourette's Syndrome; Green Tea -- Apr 1, 2004
The cells used in the study were from patients with B-cell chronic lymphocytic leukemia. It is most often diagnosed in patients in their mid- to late 60s. ... (INDYchannel.com)
Research Notebook -- Apr 6, 2004
The leukemia cells studied were from patients with B-cell chronic lymphocytic leukemia, which is most often diagnosed in patients in their mid-to-late 60s. ... (Oregonian)
Genzyme's Big Bet on Cancer -- Apr 14, 2004
Ilex provides Campath, a treatment for B-cell chronic lymphocytic leukemia, and is also testing the drug as a possible treatment for non-Hodgkin's lymphoma and ... (TheStreet.com)
Capt. Chemo, a musician and a friend brighten lives -- Apr 11, 2004
Clark is a cancer patient, diagnosed in November 2002 with a nonsymptomatic form of cancer called chronic lymphocytic leukemia. ... (Portsmouth Herald)
Genzyme moves deeper into oncology business with $1B buy of ILEX ... -- Feb 27, 2004
ILEX's lead product, Campath (alemtuzumab for injection), is indicated in the United
States for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). ... (Boston Mass High Tech, MA)
OSI Pharmaceuticals Announces Expansion and Modification of Phase ... -- Feb 25, 2004
...in June 2003. "Although we have seen some initial hints of anti-tumor activity in
pilot Phase II studies in prostate, chronic lymphocytic leukemia and renal ... (Business Wire)
Power line plan stirs opposition -- Feb 22, 2004
...pattern associating potential electromagnetic exposure with a slightly increased
risk for leukemia in children and chronic lymphocytic leukemia in adults ... (Cherry Hill Courier Post, NJ)
Antisense Making Sense? -- Feb 17, 2004
...major focus. Besides advanced melanoma, Genasense is in trials to
treat chronic lymphocytic leukemia and multiple myeloma. As I ... (Motley Fool (subscription))
Xcyte aims for $56 million in IPO -- Feb 17, 2004
...in phase 1 and 2 clinical trials of its Xcellerate technology for activating the
immune system's T cells against chronic lymphocytic leukemia and multiple ... (Puget Sound Business Journal, WA)
Pilot, newsman Ted Florko kept city up to date -- Feb 14, 2004
...through the 1990s. He died Wednesday at Vista Care Hospice in Anderson
Township of chronic lymphocytic leukemia. He was 71. Theodore W ... (Cincinnati Enquirer, OH)
Aventis/Genta Genasense Melanoma NDA Expected To Go Before FDA ... -- Feb 13, 2004
...after we get an action on the first melanoma indication." The company has advanced
Phase III programs for Genasense in myeloma and chronic lymphocytic leukemia ... (FDA Advisory Committee)
Dennis Collins 1942-2004 -- Feb 3, 2004
Miller. In 1997 Dennis was diagnosed with chronic lymphocytic leukemia
and in October 2003 he was diagnosed with lung cancer. Both ... (Miller Press, SD)
A formula for success -- Feb 3, 2004
After being diagnosed with chronic lymphocytic leukemia in 1992, Simonsen endured
chemotheraphy, radiation and a bone marrow transplant to beat the disease. ... (Journal Times Online, WI)
ADVENTRX Pharmaceuticals Appoints Dr. Mark J. Cantwell Director ... -- Feb 5, 2004
...development of Tragen's lead compound, Ad-ISF154, a recombinant adenovirus immune
therapy for the treatment of chronic lymphocytic leukemia (CLL) that advanced ... (Yahoo News)
Hickner to seek fourth term as county executive -- Feb 12, 2004
...politics was uncertain. In 1998, he was diagnosed with chronic lymphocytic
leukemia, a cancer of the white blood cells. After his ... (The Bay City Times (subscription), MI)
Running for a reason -- Jan 24, 2004
Her grandfather, Shelton Blackwell Jr., has been battling chronic lymphocytic leukemia
(CLL) for seven years, and the senior at Southwestern Randolph High ... (Asheboro Courier Tribune, NC)
Genasense(TM) Featured in Presentations at the Annual Meeting of ... -- Nov 24, 2003
Genta has also completed enrollment in two additional randomized trials
(multiple myeloma and chronic lymphocytic leukemia) with Genasense. ... (Yahoo News)
Point Therapeutics Announces Study Results Showing Additional ... -- Nov 20, 2003
...and efficacy of PT-100 in combination with Rituxan(R) in patients with hematologic
malignancies, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia ... (Business Wire)
Titan Announces Pivanex(R) Is Active Against Cancer-Related Genes -- Nov 18, 2003
In addition to this study, Titan plans to launch open label Phase II clinical studies
of Pivanex in refractory chronic lymphocytic leukemia and melanoma next ... (Yahoo News)
OSI Pharmaceuticals Announces Fiscal 2003 Financial Results; ... -- Nov 17, 2003
...to Aptosyn(R). OSI-461 is currently being evaluated in a dose-ranging Phase I study
and a series of exploratory Phase II studies in chronic lymphocytic leukemia ... (Business Wire)
Biogen and IDEC Pharmaceuticals Complete Merger to Create New ... -- Nov 12, 2003
...fumarate, which is in Phase III clinical trials in Europe; and an anti-CD23 antibody,
which will soon enter Phase II trials for chronic lymphocytic leukemia ... (Yahoo News)
Cancer personal for Deac -- Nov 11, 2003
They walked in and said, 'You've been diagnosed with a form of leukemia
called CLL (Chronic Lymphocytic Leukemia),"' Bowman recalled. ... (GoMemphis.com, TN)
Current Chronic Lymphocytic Leukemia articles
|
|
|
